AssetMark Inc’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
AssetMark Inc's BNTX Position: Q3 2026 in Review
AssetMark Inc increased its BioNTech (BNTX) stake by 13% in Q3 2026, buying an estimated $1.26K and bringing the position to 112 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.
AssetMark Inc first reported a position in BNTX in Q3 2021 and has held it in 21 quarters since. The position peaked at $388K in Q4 2021. 71 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.
- AssetMark Inc held 112 shares of BioNTech worth $11K as of Q3 2026.
- AssetMark Inc bought 13 BioNTech shares in Q3 2026, an estimated $1.26K.
- BioNTech made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2469 holding.
- AssetMark Inc first reported a position in BioNTech in Q3 2021 and has held it in 21 quarters since.
- AssetMark Inc's BioNTech position peaked at $388K in Q4 2021.
- 71 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.
Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.